Loading company…
Riskpilot
← Back to search
Sign in
Get full access
MILPHARM ApS
APS
In liquidation
CVR 35814159
Rådhuspladsen 7, 1.
Investeringsselskaber · NACE 643030
Est. 2014
— employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2021
DKK -2K
-81% vs 2020
EBITDA margin
100.0%
+81% vs 2020
Equity ratio
46.8%
Financial strength
Net profit 2021
DKK 176K
-36% vs 2020
EBITDA — year on year
DKK millions
0M
0M
1M
1M
1M
0M
2015
0M
0%
2016
0M
0%
2017
0M
0%
2018
0M
0%
2019
0M
0%
2020
0M
0%
2021
Key figures
Annual report 2021
Revenue
DKK -2K
-81%
EBITDA
DKK -2K
+81%
Net profit
DKK 176K
-36%
Total assets
DKK 1,3M
+43%
Equity
DKK 615K
+40%
Employees
—
—
Company information
Legal name
MILPHARM ApS
CVR number
35814159
Legal form
Anpartsselskab
NACE code
643030 · Investeringsselskaber
Founded
21. marts 2014
Share capital
DKK 50.000
Employees
—
VAT registered
No
Audit selected
No
Last report
2021-06-30
Financial year
January – December
Signatory rights
Virksomheden tegnes af en likvidator
Contact
Address
Rådhuspladsen 7, 1.
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Investeringsselskaber
Companies in Slagelse
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2015
0M
2016
0M
2017
0M
2018
0M
2019
0M
2020
0M
2021
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2015
0M
2016
0M
2017
0M
2018
0M
2019
0M
2020
0M
2021
Income statement
DKK thousands
Item
2015
2016
2017
2018
2019
2020
2021
Revenue
-8
-7
-7
-8
-8
-10
-2
Staff expenses
-0
-0
-0
-0
-0
-0
-0
EBITDA
-8
-7
-7
-8
-8
-10
-2
Depreciation & amort.
-0
-0
-0
-0
-0
-0
-0
EBIT
-8
-7
-7
-8
-8
-10
-2
Net financials
107
57
-6
-102
128
360
226
Profit before tax
99
50
-13
-110
120
351
224
Tax
23
11
-3
-24
29
76
48
Net profit
75
39
-10
-86
91
275
176
Balance sheet
DKK thousands
Item
2015
2016
2017
2018
2019
2020
2021
Total assets
683
606
372
279
474
921
1.313
Equity
130
170
160
73
164
439
615
Long-term debt
0
0
0
0
0
0
0
Short-term debt
553
436
213
206
310
482
699
Total debt
553
436
213
206
310
482
699
Financial ratios
5-year trend
EBITDA margin
-186700.0%
This company
15.8%
Market median
-1181746% vs market
2015
2021
Equity ratio
46.8%
This company
38.2%
Market median
+23% vs market
2015
2021
Return on equity
28.6%
This company
18.4%
Market median
+55% vs market
2015
2021
Net profit margin
17568100.0%
This company
8.1%
Market median
+216890023% vs market
2015
2021
Asset turnover
-0.00×
This company
1.12×
Market median
-100% vs market
2015
2021
Debt / equity
1.14×
This company
0.62×
Market median
-84% vs market
2015
2021
Annual reports & filings
Annual report 2021
Filed via CVR / Virk · Period 2020-07-01 – 2021-06-30
View
PDF
Annual report 2020
Filed via CVR / Virk · Period 2019-07-01 – 2020-06-30
View
PDF
Annual report 2019
Filed via CVR / Virk · Period 2018-07-01 – 2019-06-30
View
PDF
Annual report 2018
Filed via CVR / Virk · Period 2017-07-01 – 2018-06-30
View
PDF
Annual report 2017
Filed via CVR / Virk · Period 2016-07-01 – 2017-06-30
View
PDF
Annual report 2016
Filed via CVR / Virk · Period 2015-07-01 – 2016-06-30
View
PDF
Annual report 2015
Filed via CVR / Virk · Period 2014-03-21 – 2015-06-30
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Age
Other directorships
RR
René Rasmussen
Unofficial title
Unofficial title
2022
—
—
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Stella Mølgaard
Individual
50.0%
50.0%
2021
Jonas Mølgaard
Individual
50.0%
50.0%
2021
Finn Mølgaard
Individual
100.0%
100.0%
2014
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of MILPHARM ApS also hold positions in
0
other companies.
Person
Role here
Other companies
René Rasmussen
Unofficial title
0 companies